ARCHIVES

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

This article is from The Cancer Letter archive.

Vol. 40 No. 37 | October 3, 2014

Download PDF Visit The Full Archive

Related Articles

Women With Least Aggressive Subtype of Breast Cancer Still at Risk After 10 Years

September 28, 2012

Tim Lee Carter Named Chairman Of NCAB; Five Others Appointed

June 11, 1982

Adcetris Granted Approval For Hodgkin’s Lymphoma and ALCL

September 30, 2011

In Brief: Magnuson Delays Action On Apparitions Bill; No Vote See Now Until September

July 28, 1978

ACS Chief Medical Officer Brawley Urges Audit Of I-ELCAP Lung Screening Data.

September 26, 2008

New Genetic Test Approved For Breast Cancer Patients

July 25, 2008